58th Annual Meeting of Japan Society of Clinical Oncology (JSCO) is organized by Japan Society of Clinical Oncology (JSCO) and will be held from Oct 22 - 24, 2020 at Kyoto International Conference Center, Kyoto, Kansai, Japan Additional details will be posted as soon as information is available.  

Japan Digestive Disease Week (JDDW) 2020 is organized by Japan Digestive Disease Week (JDDW) and will be held from Nov 05 - 08, 2020 at Kobe Convention Center, Kobe, Hyogo, Japan. Additional details will be posted as soon as information is available.

Update in Rheumatology is organized by Continuing Education, Inc. and will be held from Nov 08 - 22, 2020 at Celebrity Millennium, Tokyo, Kanto, Japan. Target Audience: Primary Care Physicians, Internists, Physician Assistants, Nurses, Nurse Practitioners Accreditation: • 20 AMA PRA Category 1 Credits™ • 20 ACPE Credits • 20.0 Contact Hours Description: The aim of the course is to review the essence of Rheumatology for the primary care physician. We will cover updates and the new therapeutic modalities available today for the treatment of rheumatic conditions, including various aspects of biological therapy, the introduction of small molecules (tyrosine and JAK kinases inhibitors) and the important utilization of conventional disease modifying drugs. We will go over the basic autoimmune mechanisms that stand behind the pathogenesis of the autoimmune /rheumatic disorders. In addition, the course will cover our modern understanding of pain syndromes and old and new management methodologies. Given the common use of modern therapies among patents with rheumatic conditions, recognition of these mentioned topics will improve health care team performances and outcomes when managing these patients. Topics: • Rheumatoid arthritis updates ○ Understanding the disease pathogenesis and modern therapeutic modalities. • Ankylosing spondylitis ○ Understanding the disease pathogenesis and modern therapeutic modalities. • Psoriatic arthritis ○ Understanding the disease pathogenesis and modern therapeutic modalities. • Osteoarthritis ○ Understanding the disease pathogenesis and manner we can alter disease progression. • Fibromyalgia ○ Understanding the complexities of managing patients with chronic pain syndromes, the pathogenic mechanisms behind their emergence and the challenges health care teams and patients alike phase. • Systemic lupus erythematosus ○ Understanding the disease pathogenesis and heterogeneity. • Crystal induced arthritis ○ Understating the mechanisms behind gout and calcium pyrophosphate disease. • Smoking and Autoimmunity ○ introducing smoking as a facilitator of autoimmune disorders

Japanese Retina and Vitreous Society (JRVS) 59th Annual Meeting is organized by Japanese Retina and Vitreous Society (JRVS). This Onsite medical conference will be held from Dec 11 - 13, 2020 at Fukuoka Convention Center, Fukuoka, Japan. Additional details will be posted as soon as they are available.

Japan Digestive Disease Week (JDDW) is organized by Japan Digestive Disease Week (JDDW) and will be held during Nov 04 - 07, 2021 at Kobo, Hyogo, Japan. Additional details will be posted as soon as they are available.

Flow Chemistry Asia 2020 is organized by Select Biosciences and will be held from Nov 09 - 10, 2020 at Hotel Nikko Narita, Narita, Chiba, Japan. Overview: This conference is held co-located and concurrently with the SelectBIO Organoids & Organ-on-a-Chip Asia 2020 and 3D-Bioprinting Asia 2020 and delegates receive full access to these co-located conferences for maximal scientific exchange and networking opportunities. Running alongside the conference is an exhibition featuring companies showcasing their technologies and product offerings in this space. SelectBIO is honored to welcome Professor Paul Watts, Research Chair in Microfluidic Bio/Chemical Processing, Nelson Mandela University as the Conference Chairman. Additional details will be posted as soon as information is available.

3D-Bioprinting & Biofabrication Asia 2020 is organized by Select Biosciences and will be held from Nov 09 - 10, 2020 at Hotel Nikko Narita, Narita, Chiba, Japan. Overview: The interest around 3D-printing has risen spectacularly within the last few years. With continued progress, it has the potential to revolutionize the life sciences the advances in 3D printing and bioprinting technology have expansive applications in surgery, personalized medicine, diagnostics, and drug discovery. This conference will look at a wide range of technologies, applications and methodologies within the 3D printing in the life sciences space. With a well-known track record for delivering high-quality agendas, this event will include talks from some of the world’s foremost innovators in materials, applications, digital dentistry, scaffolds, cell containing constructs and tissue regeneration, and tissue engineering. Additional details will be posted as soon as information is available.

Microfluidics & Lab-on-a-Chip Asia 2020 is organized by Select Biosciences and will be held from Nov 09 - 10, 2020 at Hotel Nikko Narita, Narita, Chiba, Japan. Overview: The goal of this conference is to address the emerging technologies and themes in Microfluidics and Lab-on-a-Chip as these areas are expanding and evolving. The presentations from academic and industry speakers highlight the most up-to-date research as well as commercial trends in these fields via scientific presentations, sponsored technical presentations from companies, panel discussions as well as an exhibit hall and scientific workshops. Topics: • Developments in Materials and Microfabrication Technologies • Emerging Themes and Approaches in Microfluidics/LOAC ○ Droplet Microfluidics, Digital Microfluidics, Centrifugal Microfluidics ○ Cell Capture of Clinically-Relevant Cellular Sub-Populations such as CTCs ○ Circulating Biomarkers • Microfluidic/LOAC Device Manufacturing: Technologies and Companies Showcase • Microfluidics/LOAC: Life Science Research Applications ○ Rapid, Low-Cost Diagnostics ○ Research Trends Additional details will be posted as soon as information is available.

Cell & Gene Therapy and Cancer Immunotherapy Asia 2020 is organized by Select Biosciences and will be held from Nov 12 - 13, 2020 at obe Bay Sheraton Hotel & Towers, kobe, Hyogo, Japan.  Description: This conference brings together academic and industry participants focusing on many aspects of this rapidly expanding and evolving field including stem cells for cellular therapy, ESCs and iPSCs and their deployment for cell & gene therapy, cancer immunotherapy including CAR-T therapy, and clinical application and technologies for gene therapy. The conference addresses the whole ecosystem of Cell & Gene Therapy and Cancer Immunotherapy with a focus on technology platforms being developed to bring cell & gene therapy and regenerative medicine to the clinic. Topics: • Biomarkers & Companion Diagnostics for Targeting Cancer Immunotherapy • Checkpoint and Non-Checkpoint Immunotherapies • Chimeric Antigen Receptor (CAR) T-Cells in Cancer Immunotherapy • Clinical Trials and Commercialization of Cell Therapies • Combination Cancer Immunotherapy • ESC and iPSC-derived Cells for Cellular Therapy and Clinical Deployment • Gene Therapy into the Clinic ○ Clinical Pipeline ○ Regulatory Landscape ○ Technology Platforms • Immunomodulatory Antibodies • Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy • Small Molecules in Cancer Immunotherapy • Stem Cells for Cellular Therapy • Targeting Signaling Pathways in Cancer as Therapeutic Intervention Additional details will be posted as soon as information is available.

Adult Stem Cells & Exosome-based Therapeutics 2020 is organized by Select Biosciences and will be held from Nov 12 - 13, 2020 at obe Bay Sheraton Hotel & Towers, kobe, Hyogo, Japan. Overview: SelectBIO Adult Stem Cells & Exosome/EV-based Therapeutics Asia 2020 brings together the most up-to-date technologies and advances in this expanding and evolving field.  Our coverage in this conference focuses on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas: • Extracellular Vesicles Produced by Adult Stem Cells and their Functional Activities • Exosome/EV Engineering • Exosomes/EV-based Therapeutics Development and Regenerative Medicine This conference features an international faculty of speakers from academia as well as industry addressing the following topic areas: • Technologies for Isolation and Characterization as Well as High-Volume Production of EVs for Potential Therapeutics Applications • Exosomes/EVs Derived from Adult Stem Cells and Their Theraeputic/Regenerative Properties • Role in Cancer and Various Disease Classes -- Regenerative Medicine • Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development • Regulatory Landscape in the Use of Exosomes/EVs for Therapeutics The ability to engineer EVs and the ability of EVs to target specific sites offers the ability to tailor therapeutics with "exquisite targeting ability" and opens up a whole new class of therapeutics which are classified as biologicals and which do not have the side effects and toxicity associated with small molecule-based therapies. This conference explores this topic and takes a deep dive into the technology platforms, diseases targeted and clinical results-to-date based on research involving stem cells and stem cell-derived extracellular vesicles (EVs) for clinical utility and regenerative medicine. Additional details will be posted as soon as information is available.